http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/9163271.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/3261062.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/9529923.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/1547604.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/4997225.png
Dispensary of diabetes on NHIF
For children under 18 years of age with diabetes dispensary observation is conducted by endocrinologist. National Health Insurance Fund (NHIF) pays 12 annual review, consultation with a narrow specialist (nephrologist, ophthalmologist, neurologist, etc.). - once a year and the following tests: blood-glycose profile (BGP), glycosylated hemoglobin, cholesterol, triglycerides, microalbuminuria - twice a year.
The NHIF pays three dispensaries of patients with type 2 diabetes mellitus annually review a GP. Required once a year the patient consult a specialist endocrinologist who employs urine tests for microalbuminuria (for early detection of kidney disease - initial nephropathy).
General practitioner appointed 2 times annual survey of glycosylated hemoglobin or KZP - 2 to 4 times a year. If the disease runs a complication health insurance pay an additional consultation with the relevant profile specialist (neurologist, ophthalmologist, surgeon or vascular surgeon) - once every two years.
Patients with diabetes on insulin therapy over the age of 18 dispensary monitoring is carried out by a specialist in endocrinology. NHIF pays for patients with diabetes on insulin therapy three dispensaries in the annual review endocrinologist, which include general clinical status with a focus on cardiovascular and nervous system. Once a year must be made ECG or in the oppinion of the doctor - in every review.
Twice a year is determined by blood glucose glyukomer. KZP is investigated, glycosylated hemoglobin, urine sediment, creatinine, cholesterol.
If the disease runs a complication health insurance pay an additional consultation with the relevant profile specialist (neurologist, ophthalmologist, nephrologist, vascular surgeon or surgeon) - once a year.
Health insurance policy for the prevention of diabetes
Each year, the general practitioner (GP) performed prophylactic examinations of all health insured patient from his list. In prophylactic examinations of people over the age of 18, unless all activities are also included: determination of blood glucose with glyukomer and testing of urine test strips (for protein, glucose, ketone bodies, urobilinogen / bilirubin and pH).
In the screening, GPs are held in Pledge, in view of socialsignificant and prevention of priority diseases in the country, the doctor formed a risk group "Diabetes Mellitus" in specific categories of people:
- with a family history of type 2 diabetes
- with arterial hypertension
- with dyslipidemia
- with reduced glucose tolerance
Insured over the age of 18, included in this risk group are subject to preventive review once a year for a specialist in endocrinology and metabolism diseases.
Care and services for diabetic patients in out of hospital care
All patients with diagnosed diabetes are observed dispensary of the general practitioner (GP) or a specialist in endocrinology and metabolism diseases.
GPs observes patients over 18 years of age with type 2 diabetes mellitus on treatment with oral antidiabetic drugs.
The specialist in endocrinology and metabolism diseases monitor:
- For persons under 18 years of age with type 1 diabetes and diabetes with ophthalmic complications
- For persons over the age of 18 have type 1 diabetes, type 2 diabetes to treatment with oral antidiabetic drugs and / or diet and diabetic polyneuropathy
Dispensary observation is carried out by a specialist issued by a single strand of the GP to a specialist for the duration of the dispensary observation.
Dispensary observation of all types are subject to diabetes and diabetes including the diabetes with complications.